(Q37222600)

19 August 2017

1 reference

title

Use of quinolones in the treatment of gastrointestinal infections (English)

1 reference

19 August 2017

0 references

H. L. DuPont

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1864292

12 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1864292

12 December 2022

publication date

1 April 1991

1 reference

full work available at URL

19 August 2017

http://link.springer.com/content/pdf/10.1007/BF01967006.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01967006/fulltext.html

12 December 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF01967006

12 December 2022

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

12 December 2022

published in

1 reference

19 August 2017

10

1 reference

19 August 2017

4

1 reference

19 August 2017

325-329

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01967006

19 August 2017

0 references

cites work

Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

Antimicrobial susceptibility of Aeromonas species isolated from patients with diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

Susceptibilities of Hong Kong isolates of multiply resistant Shigella spp. to 25 antimicrobial agents, including ampicillin plus sulbactam and new 4-quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

Bicozamycin, A Poorly Absorbable Antibiotic, Effectively Treats Travelers' Diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

Effects of erythromycin and ciprofloxacin on chronic fecal excretion of Campylobacter species in marmosets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

Lack of emergence of resistant fecal flora during successful prophylaxis of traveler's diarrhea with norfloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

Effect of oral ofloxacin on fecal bacteria in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967006

Juvenile canine drug-induced arthropathy: Clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids

21 January 2018

1 reference

12 December 2020

Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea

1 reference

12 December 2020

Nalidixic acid in Shigella dysenteriae outbreaks

1 reference

12 December 2020

Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis

1 reference

12 December 2020

Nalidixic acid in children: retrospective matched controlled study for cartilage toxicity

1 reference

12 December 2020

Use of norfloxacin in the treatment of acute diarrheal disease

1 reference

12 December 2020

The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens

1 reference

12 December 2020

Nalidixic acid for shigellosis

1 reference

12 December 2020

Detection of enteropathogens in fatal and potentially fatal diarrhea in Cairo, Egypt

1 reference

12 December 2020

Multiple transmissible drug resistance in an outbreak of Shigella flexneri infection

1 reference

12 December 2020

Apparent absence of transferable resistance to nalidixic acid in pathogenic Gram-negative bacteria

1 reference

12 December 2020

Resistance of Shigella, Salmonella, and other selected enteric pathogens to antimicrobial agents

1 reference

12 December 2020

Impact of oral ciprofloxacin on the faecal flora of healthy volunteers

1 reference

12 December 2020

Problems in identification of Campylobacter jejuni associated with acquisition of resistance to nalidixic acid.

1 reference

12 December 2020

Drug resistance in Shigella dysenteriae, S flexneri and S boydii in England and Wales: increasing incidence of resistance to trimethoprim

1 reference

12 December 2020

Ciprofloxacin: an update on clinical experience.

1 reference

12 December 2020

Efficacy of trimethoprim-sulfamethoxazole in treatment of acute diarrhea in a Mexican pediatric population

1 reference

12 December 2020

Multiply drug-resistant Shigella dysenteriae type 1 and travelers' diarrhea

1 reference

12 December 2020

Trimethoprim-sulfamethoxazole therapy for shigellosis

1 reference

12 December 2020

Effect of oral ciprofloxacin on the faecal flora of healthy volunteers.

1 reference

12 December 2020

The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms

1 reference

12 December 2020

Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone

1 reference

12 December 2020

Controlled comparison of nalidixic acid or lactulose with placebo in shigellosis

1 reference

12 December 2020

Norfloxacin versus placebo for prophylaxis against travellers' diarrhoea

1 reference

12 December 2020

Effect of Antibiotic Therapy in Acute Salmonellosis on the Fecal Excretion of Salmonellae

1 reference

12 December 2020

American Journal of Medicine

15

82

381

G Areieri

1987

1 reference

American Journal of Medicine

12 December 2022

35

82

329

HET Pichler

1987

1 reference

12 December 2022

Identifiers

DOI

10.1007/BF01967006

1 reference

19 August 2017

1 reference